Published in J Gen Virol on March 01, 1984
Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J Virol (1991) 2.36
Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol (1988) 1.90
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol (1990) 1.44
Detection of hepatitis A virus in sewage sludge by antigen capture polymerase chain reaction. Appl Environ Microbiol (1993) 1.42
Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J Virol (2005) 1.38
Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci U S A (1989) 1.30
Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J Virol (1989) 1.23
Persistence of echovirus 6 in cloned human cells. J Virol (1985) 1.17
Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology (1990) 1.08
Restricted replication of hepatitis A virus in cell culture: encapsidation of viral RNA depletes the pool of RNA available for replication. J Virol (1988) 1.07
Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl. J Virol (1985) 1.01
Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection. J Virol (1988) 0.98
A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J Virol (1998) 0.95
Silencing of hepatitis A virus infection by small interfering RNAs. J Virol (2006) 0.93
Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA. J Virol (2002) 0.91
Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J Virol (1993) 0.85
A review of the possible mechanisms for the persistence of foot-and-mouth disease virus. Epidemiol Infect (1995) 0.84
Hepatitis A virus suppresses monocyte-to-macrophage maturation in vitro. J Virol (2002) 0.80
Behind closed membranes: the secret lives of picornaviruses? PLoS Pathog (2013) 0.80
Myelopoiesis in vitro is suppressed by hepatitis A virus. Ann Hematol (1992) 0.79
Innate and adaptive immune responses against picornaviruses and their counteractions: An overview. World J Virol (2012) 0.78
Suppression of La antigen exerts potential antiviral effects against hepatitis A virus. PLoS One (2014) 0.76
Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection. J Virol (2006) 0.76
Hepatology. Postgrad Med J (1991) 0.75
Indirect immunofluorescence assay for the detection of hepatitis A virus-specific serum immunoglobulins. J Clin Microbiol (1986) 0.75
A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus. J Infect Dis (1979) 3.15
Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol (1980) 2.13
Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet (1991) 2.02
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood (1991) 1.74
Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (2002) 1.70
Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J Infect Dis (1983) 1.56
Detection of hepatitis A virus in sewage sludge by antigen capture polymerase chain reaction. Appl Environ Microbiol (1993) 1.42
Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A. J Med Virol (1977) 1.39
Hepatitis A-virus in cell culture: I. propagation of different hepatitis A-virus isolates in a fetal rhesus monkey kidney cell line (Frhk-4). Med Microbiol Immunol (1980) 1.39
Malignant external otitis: a case report and review. Am Fam Physician (1994) 1.38
Liver-derived cytotoxic T cells in hepatitis A virus infection. J Infect Dis (1989) 1.29
Early diagnosis of herpes simplex encephalitis by MRI. Neurology (1987) 1.28
Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology (1987) 1.23
Hepatitis A virus in cell culture. II. Growth characteristics of hepatitis A virus in Frhk-4/R cells. Med Microbiol Immunol (1981) 1.21
Acid stability of hepatitis A virus. J Gen Virol (1989) 1.18
Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology (1990) 1.08
Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood (1993) 1.06
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol (2000) 1.06
Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation. Virology (1994) 1.02
Antigenicity of hepatitis A virus after ultra-violet inactivation. Vaccine (1995) 1.02
Hepatitis A virus in cell culture. III. Propagation of hepatitis A virus in human embryo kidney cells and human embryo fibroblast strains. Med Microbiol Immunol (1981) 0.99
Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection. J Virol (1988) 0.98
A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J Virol (1998) 0.95
Comparison of ozone inactivation, in flowing water, of hepatitis A virus, poliovirus 1, and indicator organisms. Appl Environ Microbiol (1989) 0.95
Application of a solid-phase radioimmunoassay and immune electron microscopy for hepatitis A in diagnosis and research. Med Microbiol Immunol (1978) 0.93
Hepatitis A virus infection and the interferon system. J Infect Dis (1985) 0.91
Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature (1981) 0.91
The p53 family inhibitor DeltaNp73 interferes with multiple developmental programs. Cell Death Differ (2006) 0.91
Recombination of influenza A strains with fowl plague virus can change pneumotropism for mice to a generalized infection with involvement of the central nervous system. Virology (1980) 0.91
Isolation and primary structure of the gene encoding fructose-1,6-bisphosphatase from Saccharomyces cerevisiae. FEBS Lett (1988) 0.90
High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation (1988) 0.90
Modeling of a segmented electrode for desynchronizing deep brain stimulation. Front Neuroeng (2011) 0.89
Properties of a hepatitis A virus candidate vaccine strain. J Gen Virol (1987) 0.88
Autoantibodies against human beta interferon following treatment with interferon. J Interferon Res (1982) 0.88
Hepatitis A-virus particles in stools of patients from a natural hepatitis outbreak in Germany. Med Microbiol Immunol (1977) 0.88
Levels of neutralizing and binding antibodies to hepatitis-A virus after onset of icterus: a comparison. J Infect Dis (1984) 0.87
Genetic relatedness of Cuban HAV wild-type isolates. J Med Virol (2001) 0.86
The proposed gene for VP1 of HAV encodes for a larger protein than that observed in HAV-infected cells and virions. Virology (1995) 0.85
Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J Med Virol (1996) 0.85
Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection. J Med Virol (1986) 0.84
Immunogenicity of a hepatitis A virus vaccine. J Med Virol (1987) 0.84
Transmission of hepatitis A virus infection despite vaccination. N Engl J Med (2000) 0.84
Detection of hepatitis A virus RNA in commercially available factor VIII preparation. Lancet (1992) 0.84
[Amniotic infection syndrome after amniocentesis--a case report]. Geburtshilfe Frauenheilkd (1982) 0.83
New epidemiological patterns of hepatitis A and B infections in Germany. Zentralbl Hyg Umweltmed (1995) 0.83
Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update. Vox Sang (1994) 0.83
Isolated pericardial relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant (1989) 0.83
Significant reduction of cytomegalovirus (CMV) disease by prophylaxis with CMV hyperimmune globulin plus oral acyclovir. Bone Marrow Transplant (1988) 0.83
Irreversible inactivation of Saccharomyces cerevisiae fructose-1,6-bisphosphatase independent of protein phosphorylation at Ser11. FEBS Lett (1988) 0.82
Influence of the 5' noncoding region of hepatitis A virus strain GBM on its growth in different cell lines. J Gen Virol (1997) 0.81
Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription. Nucleic Acids Res (1994) 0.81
Influenza virus: association of mouse-lung virulence with plaque formation in mouse kidney cells. Intervirology (1976) 0.81
Inhibition of in vitro hematopoiesis by hepatitis A virus. Exp Hematol (1987) 0.81
Antitumor activity of the pineal gland: effect of unidentified substances versus the effect of melatonin. Oncology (1992) 0.80
A comparison of enzyme-immunoassay and radioimmunoassay for detection of hepatitis A virus and antibodies against hepatitis A virus. J Biol Stand (1984) 0.80
Interferon-gamma secretion by in vivo activated cytotoxic T lymphocytes from the blood and cerebrospinal fluid during mumps meningitis. J Neuroimmunol (1991) 0.80
Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients. Eur J Med Res (2011) 0.79
Characterization of cell mediated immune responses to the hepatitis B core protein in man. Clin Exp Immunol (1987) 0.79
Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children. J Med Virol (1996) 0.79
Myelopoiesis in vitro is suppressed by hepatitis A virus. Ann Hematol (1992) 0.79
Immune response to hepatitis A virus capsid proteins after infection. J Clin Microbiol (1996) 0.78
Gamma vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission. Neuropsychopharmacology (2001) 0.78
[Polyols derived from sterols and sterol derivatives. VI. Steroids containing structural units of the ecdyson and elatericines]. Justus Liebigs Ann Chem (1972) 0.78
Acute viral hepatitis, types A, B and non-A, non-B: a prospective study of the epidemiological, laboratory and prognostic aspects in 280 consecutive cases. Scand J Infect Dis (1981) 0.78
Detection of hepatitis A virus in a factor VIII preparation by antigen capture/PCR. Vox Sang (1994) 0.78
Molecular epidemiology of an outbreak of hepatitis A in Italy. J Med Virol (1995) 0.77
Improvement of virus safety of a S/D-treated factor VIII concentrate by additional dry heat treatment at 100 degrees C. Biologicals (1996) 0.77
A severe human cowpox infection in south Germany. Pediatr Infect Dis J (1988) 0.76
Influenza virus: appearance of high mouse-neurovirulent recombinants. Intervirology (1979) 0.76
Functional significance of neuraminidase in the replication cycle of influenza viruses. Zentralbl Bakteriol Orig A (1975) 0.76
[Oral prophylaxis of herpes infections using acyclovir following bone marrow transplantation: a clinical and clinico-pharmacological study]. Klin Wochenschr (1986) 0.76
Hepatitis C virus, rheumatoid factors, and disease progression. Lancet (1998) 0.75
Hepatitis A-virus in cell culture. V. Neutralizing antibodies against hepatitis A-virus. Med Microbiol Immunol (1984) 0.75
Hybridization techniques provide improved sensitivity for HCMV detection and allow quantitation of the virus in clinical samples. J Virol Methods (1989) 0.75
Hepatitis G virus infection. Lancet (1997) 0.75
Clinical problem-solving: we blew it. N Engl J Med (1995) 0.75
Preliminary characterization of a fast-growing strain of human hepatitis A virus. Microbiologica (1986) 0.75
Hepatitis A-virus in cell culture. IV. Comparison of cell-culture-produced HAV with stool-derived HAV in diagnostic test systems. Med Microbiol Immunol (1984) 0.75
[Results from the hepatitis A-virus diagnostic of the hygiene-institut in Tübingen]. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.75
Durability of enzyme activity in serum. Ger Med Mon (1966) 0.75
Acute viral hepatitis A, B and non-A, non-B in Stockholm in the 1950s and 1970s: a comparison. Infection (1981) 0.75
[Epidemiology and clinical aspects of non-A, non-B hepatitis (author's transl)]. Dtsch Med Wochenschr (1980) 0.75